These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 34635857)
1. Challenges with benchmarking of MDMA-assisted psychotherapy. Halvorsen JØ; Naudet F; Cristea IA Nat Med; 2021 Oct; 27(10):1689-1690. PubMed ID: 34635857 [No Abstract] [Full Text] [Related]
2. The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD. Brewerton TD; Lafrance A; Mithoefer MC Med Hypotheses; 2021 Jan; 146():110367. PubMed ID: 33203569 [TBL] [Abstract][Full Text] [Related]
3. Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy. Mitchell J; Coker A; Yazar-Klosinski B Nat Med; 2021 Oct; 27(10):1691-1692. PubMed ID: 34635856 [No Abstract] [Full Text] [Related]
4. MDMA-assisted psychotherapy for the treatment of PTSD. Reiff CM; McDonald WM Braz J Psychiatry; 2021; 43(2):123-124. PubMed ID: 33053043 [No Abstract] [Full Text] [Related]
5. MDMA assisted psychotherapy found to have a large effect for chronic post-traumatic stress disorder. Chabrol H J Psychopharmacol; 2013 Sep; 27(9):865-6. PubMed ID: 23981728 [No Abstract] [Full Text] [Related]
6. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel. Cipriani A; Cowen PJ Lancet Psychiatry; 2018 Jun; 5(6):453-455. PubMed ID: 29728332 [No Abstract] [Full Text] [Related]
7. Premise, promise and challenges of MDMA assisted therapy for PTSD. Madero S; Alvarez OD Eur Neuropsychopharmacol; 2023 May; 70():19-20. PubMed ID: 36806884 [No Abstract] [Full Text] [Related]
8. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331 [TBL] [Abstract][Full Text] [Related]
9. MDMA-assisted psychotherapy for posttraumatic stress disorder: A promising novel approach to treatment. Vermetten E; Yehuda R Neuropsychopharmacology; 2020 Jan; 45(1):231-232. PubMed ID: 31455855 [No Abstract] [Full Text] [Related]
11. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). Oehen P; Traber R; Widmer V; Schnyder U J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy. Wagner MT; Mithoefer MC; Mithoefer AT; MacAulay RK; Jerome L; Yazar-Klosinski B; Doblin R J Psychopharmacol; 2017 Aug; 31(8):967-974. PubMed ID: 28635375 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis. Bahji A; Forsyth A; Groll D; Hawken ER Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109735. PubMed ID: 31437480 [TBL] [Abstract][Full Text] [Related]
14. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil. Jardim AV; Jardim DV; Chaves BR; Steglich M; Ot'alora G M; Mithoefer MC; da Silveira DX; Tófoli LF; Ribeiro S; Matthews R; Doblin R; Schenberg EE Braz J Psychiatry; 2021; 43(2):181-185. PubMed ID: 32638920 [TBL] [Abstract][Full Text] [Related]
15. Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy. Feduccia AA; Jerome L; Mithoefer MC; Holland J Psychopharmacology (Berl); 2021 Feb; 238(2):581-588. PubMed ID: 33221932 [TBL] [Abstract][Full Text] [Related]
16. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Mithoefer MC; Feduccia AA; Jerome L; Mithoefer A; Wagner M; Walsh Z; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R Psychopharmacology (Berl); 2019 Sep; 236(9):2735-2745. PubMed ID: 31065731 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials. Jerome L; Feduccia AA; Wang JB; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R Psychopharmacology (Berl); 2020 Aug; 237(8):2485-2497. PubMed ID: 32500209 [TBL] [Abstract][Full Text] [Related]
18. MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms? Feduccia AA; Mithoefer MC Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):221-228. PubMed ID: 29524515 [TBL] [Abstract][Full Text] [Related]